Literature DB >> 19428827

Australia's national Q fever vaccination program.

Heather F Gidding1, Cate Wallace, Glenda L Lawrence, Peter B McIntyre.   

Abstract

A nationally funded Q fever vaccination program was introduced in Australia in 2002. The evaluation of this unique program included measures of program uptake, safety, and notification and hospitalisation rates for Q fever pre- and post-program implementation. Program uptake ranged from close to 100% amongst abattoir workers to 43% in farmers. The most commonly reported adverse event was injection site reaction. Q fever notification rates declined by over 50% between 2002 and 2006, particularly in young adult males, consistent with the profile of the abattoir workforce. Hospitalisation data showed similar trends. Available evidence suggests a significant impact of Australia's Q fever vaccination program; such a program merits consideration in other countries with a comparable Q fever disease burden.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428827     DOI: 10.1016/j.vaccine.2009.02.007

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  32 in total

1.  Q fever seroprevalence in metropolitan samples is similar to rural/remote samples in Queensland, Australia.

Authors:  S J Tozer; S B Lambert; T P Sloots; M D Nissen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-16       Impact factor: 3.267

2.  Coxiella burnetii - Pathogenic Agent of Q (Query) Fever.

Authors:  Lutz Gürtler; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-12-23       Impact factor: 3.747

Review 3.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

4.  Identification of Coxiella burnetii CD8+ T-Cell Epitopes and Delivery by Attenuated Listeria monocytogenes as a Vaccine Vector in a C57BL/6 Mouse Model.

Authors:  Xiaolu Xiong; Jun Jiao; Anthony E Gregory; Pengcheng Wang; Yujing Bi; Xiaoyi Wang; Yongqiang Jiang; Bohai Wen; Daniel A Portnoy; James E Samuel; Chen Chen
Journal:  J Infect Dis       Date:  2017-05-15       Impact factor: 5.226

5.  Validation of an Indirect Immunofluorescence Assay and Commercial Q Fever Enzyme-Linked Immunosorbent Assay for Use in Macropods.

Authors:  Mark A Stevenson; Simon M Firestone; Anita Tolpinrud; John Stenos; Anne-Lise Chaber; Joanne M Devlin; Catherine Herbert; An Pas; Magdalena Dunowska
Journal:  J Clin Microbiol       Date:  2022-06-02       Impact factor: 11.677

6.  Major Histocompatibility Complex Class II-Restricted, CD4+ T Cell-Dependent and -Independent Mechanisms Are Required for Vaccine-Induced Protective Immunity against Coxiella burnetii.

Authors:  Lindsey Ledbetter; Rama Cherla; Catherine Chambers; Yan Zhang; William J Mitchell; Guoquan Zhang
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

7.  Trends and risk factors for human Q fever in Australia, 1991-2014.

Authors:  T S Sloan-Gardner; P D Massey; P Hutchinson; K Knope; E Fearnley
Journal:  Epidemiol Infect       Date:  2016-12-08       Impact factor: 4.434

8.  Reduction of Coxiella burnetii prevalence by vaccination of goats and sheep, The Netherlands.

Authors:  Lenny Hogerwerf; René van den Brom; Hendrik I J Roest; Annemarie Bouma; Piet Vellema; Maarten Pieterse; Daan Dercksen; Mirjam Nielen
Journal:  Emerg Infect Dis       Date:  2011-03       Impact factor: 6.883

9.  Q Fever: current state of knowledge and perspectives of research of a neglected zoonosis.

Authors:  Sarah Rebecca Porter; Guy Czaplicki; Jacques Mainil; Raphaël Guattéo; Claude Saegerman
Journal:  Int J Microbiol       Date:  2011-12-13

10.  Seroepidemiological survey for Coxiella burnetii antibodies and associated risk factors in Dutch livestock veterinarians.

Authors:  René Van den Brom; Barbara Schimmer; Peter M Schneeberger; Wim A Swart; Wim van der Hoek; Piet Vellema
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.